REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 195 filers reported holding REVANCE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.35 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $26,760,749 | -48.4% | 2,333,108 | +13.8% | 0.00% | -66.7% |
| Q2 2023 | $51,905,292 | -17.3% | 2,050,782 | +5.3% | 0.00% | -25.0% |
| Q1 2023 | $62,737,446 | -17.1% | 1,947,763 | -52.5% | 0.00% | +100.0% |
| Q4 2022 | $75,671,048 | +73.4% | 4,099,190 | +153.6% | 0.00% | -33.3% |
| Q3 2022 | $43,644,000 | +77.4% | 1,616,453 | -9.2% | 0.00% | +200.0% |
| Q2 2022 | $24,597,000 | -18.2% | 1,779,793 | +15.5% | 0.00% | 0.0% |
| Q1 2022 | $30,058,000 | +17.5% | 1,541,437 | -1.6% | 0.00% | 0.0% |
| Q4 2021 | $25,571,000 | -39.1% | 1,566,846 | +3.9% | 0.00% | -50.0% |
| Q3 2021 | $42,008,000 | -1.3% | 1,507,838 | +5.0% | 0.00% | 0.0% |
| Q2 2021 | $42,576,000 | +12.7% | 1,436,444 | +6.3% | 0.00% | 0.0% |
| Q1 2021 | $37,765,000 | -9.4% | 1,351,166 | -8.1% | 0.00% | -33.3% |
| Q4 2020 | $41,668,000 | +23.7% | 1,470,276 | +9.7% | 0.00% | +50.0% |
| Q3 2020 | $33,698,000 | +2.2% | 1,340,406 | -0.7% | 0.00% | 0.0% |
| Q2 2020 | $32,969,000 | +92.2% | 1,350,080 | +16.5% | 0.00% | 0.0% |
| Q1 2020 | $17,154,000 | +0.1% | 1,159,055 | +9.8% | 0.00% | +100.0% |
| Q4 2019 | $17,129,000 | +28.9% | 1,055,390 | +3.3% | 0.00% | 0.0% |
| Q3 2019 | $13,288,000 | +9.1% | 1,022,121 | +8.8% | 0.00% | 0.0% |
| Q2 2019 | $12,180,000 | -5.0% | 939,072 | +15.4% | 0.00% | 0.0% |
| Q1 2019 | $12,820,000 | -5.8% | 813,443 | +20.3% | 0.00% | 0.0% |
| Q4 2018 | $13,612,000 | -23.9% | 676,222 | -6.1% | 0.00% | 0.0% |
| Q3 2018 | $17,895,000 | -2.6% | 720,146 | +7.6% | 0.00% | -50.0% |
| Q2 2018 | $18,372,000 | +0.6% | 669,325 | +12.9% | 0.00% | 0.0% |
| Q1 2018 | $18,259,000 | +10.7% | 592,910 | +28.5% | 0.00% | +100.0% |
| Q4 2017 | $16,491,000 | +28.4% | 461,360 | -1.0% | 0.00% | 0.0% |
| Q3 2017 | $12,841,000 | +7.5% | 466,097 | +3.0% | 0.00% | 0.0% |
| Q2 2017 | $11,944,000 | +27.7% | 452,490 | +0.6% | 0.00% | 0.0% |
| Q1 2017 | $9,356,000 | +39.0% | 449,853 | +38.4% | 0.00% | 0.0% |
| Q4 2016 | $6,729,000 | +34.8% | 325,148 | +5.7% | 0.00% | 0.0% |
| Q3 2016 | $4,990,000 | -14.6% | 307,738 | -28.3% | 0.00% | 0.0% |
| Q2 2016 | $5,840,000 | -36.6% | 429,482 | -18.6% | 0.00% | 0.0% |
| Q1 2016 | $9,206,000 | -30.7% | 527,316 | +35.6% | 0.00% | 0.0% |
| Q4 2015 | $13,281,000 | +97.3% | 388,796 | +72.0% | 0.00% | 0.0% |
| Q3 2015 | $6,733,000 | +8.9% | 226,106 | +17.0% | 0.00% | 0.0% |
| Q2 2015 | $6,185,000 | +168.0% | 193,221 | +73.4% | 0.00% | – |
| Q1 2015 | $2,308,000 | +31.4% | 111,425 | +7.4% | 0.00% | – |
| Q4 2014 | $1,756,000 | -8.3% | 103,742 | +4.9% | 0.00% | – |
| Q3 2014 | $1,914,000 | -38.3% | 98,859 | +8.4% | 0.00% | – |
| Q2 2014 | $3,103,000 | +50.4% | 91,229 | +39.3% | 0.00% | – |
| Q1 2014 | $2,063,000 | – | 65,495 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 4,405,039 | $118,936,000 | 9.40% |
| Essex Woodlands Management, Inc. | 457,085 | $12,341,000 | 5.10% |
| Evolutionary Tree Capital Management, LLC | 191,868 | $5,180,000 | 4.98% |
| Ghost Tree Capital, LLC | 390,000 | $10,530,000 | 2.96% |
| Antara Capital LP | 4,069,400 | $109,874,000 | 2.90% |
| RICE HALL JAMES & ASSOCIATES, LLC | 896,754 | $24,212,000 | 1.40% |
| Jericho Capital Asset Management L.P. | 714,000 | $19,278,000 | 1.22% |
| Antara Capital LP | 1,600,000 | $43,200,000 | 1.14% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 120,000 | $3,240,000 | 1.04% |
| TANG CAPITAL MANAGEMENT LLC | 287,500 | $7,763,000 | 0.95% |